EN
登录

实验室自动化公司Automata完成4500万美元C轮融资,与Beckman Coulter Life Sciences达成合作

Automata Raises $45M in Series C Financing Round, Partners With Beckman Coulter Life Sciences

GenomeWeb 等信源发布 2026-01-29 23:48

可切换为仅中文


NEW YORK – UK-based lab automation firm Automata said on Thursday that it has closed a $45 million Series C funding round.

纽约——英国实验室自动化公司 Automata 周四表示,已完成 4500 万美元的 C 轮融资。

Dimension led the round, joined by Danaher Ventures, Tru Arrow Partners, Octopus Ventures, and Entrepreneurs First, among others. In a statement, Automata said it would use the funds to add customers, build the next version of its data and software platform, and expand operations around the world.

Dimension领投了这一轮,Danaher Ventures、Tru Arrow Partners、Octopus Ventures和Entrepreneurs First等也参与其中。Automata在一份声明中表示,将利用这笔资金增加客户,构建其数据和软件平台的下一版本,并在全球范围内扩展业务。

Automata also announced a strategic partnership with Danaher subsidiary Beckman Coulter Life Sciences (BCLS). Under the terms of the deal, technologies from Danaher companies including BCLS and Molecular Devices will integrate Automata's software, which aims to connect lab hardware with advanced artificial intelligence-based computational models.

Automata 还宣布与丹纳赫子公司贝克曼库尔特生命科学 (BCLS) 达成战略合作伙伴关系。根据协议条款,包括 BCLS 和 Molecular Devices 在内的丹纳赫公司的技术将整合 Automata 的软件,该软件旨在将实验室硬件与基于先进人工智能的计算模型连接起来。

Danaher executive Murali Venkatesan will join the firm's board of directors. .

丹纳赫公司的高管穆拉利·文卡特桑将加入该公司董事会。

'AI-first biology requires fundamentally different infrastructure,' Mostafa Elsayed, CEO of Automata, said in a statement. 'We're building the operating layer between AI models and the physical lab, enabling labs to run autonomously rather than as bespoke workshops. This funding allows us to scale that vision with customers who are already redefining what's possible in experimental science.'.

“以人工智能为先的生物学需要完全不同的基础设施,”Automata首席执行官Mostafa Elsayed在一份声明中表示。“我们正在构建人工智能模型与实体实验室之间的操作层,使实验室能够自主运行,而不是作为定制化的工作坊。这笔资金使我们能够与那些已经在重新定义实验科学可能性的客户一起扩展这一愿景。”

The deal is the latest automation-focused partnership for BCLS. In November, it partnered with fellow Danaher subsidiary

该交易是BCLS最新的自动化合作伙伴关系。去年11月,它与同为丹纳赫子公司的公司合作。

IDT

集成设备技术公司

to automate targeted sequencing assays and hybrid capture workflows. In September, it

以自动化目标测序分析和杂交捕获工作流程。今年九月,它

partnered

合伙的

with Switzerland's Hombrechtikon Systems Engineering to automate nucleic acid quantification.

与瑞士的Hombrechtikon系统工程公司合作,实现核酸定量的自动化。

BCLS has also

BCLS 也

partnered

合作的

with 10x Genomics to automate single-cell sequencing.

与10x Genomics合作,实现单细胞测序的自动化。